Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction--a hospital registry-primary care linked cohort (MINAP-GPRD).
about
Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER)Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designsClinical disease registries in acute myocardial infarctionProlonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populationsComparison of hospital variation in acute myocardial infarction care and outcome between Sweden and United Kingdom: population based cohort study using nationwide clinical registriesThe CPRD and the RCGP: building on research success by enhancing benefits for patients and practicesRecent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource.Evidence of poor adherence to secondary prevention after acute coronary syndromes: possible remedies through the application of new technologiesCost-effectiveness analysis of treatment of venous thromboembolism with rivaroxaban compared with combined low molecular weight heparin/vitamin K antagonist.Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap.Patterns of antiplatelet drug use after a first myocardial infarction during a 10-year period.Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study.Use of medicines recommended for secondary prevention of acute coronary syndrome.Effect of exposure to evidence-based pharmacotherapy on outcomes after acute myocardial infarction in older adults.Almanac 2011: Acute Coronary Syndromes. The National Society Journals Present Selected Research that has Driven Recent Advances in Clinical Cardiology.Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke.Safety of temporary and permanent suspension of antiplatelet therapy after drug eluting stent implantation in contemporary "real-world" practiceBridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.Medicines Compliance and Reimbursement Level in Portugal.Cardiovascular medication use following percutaneous coronary intervention: the Australian experience.Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with percutaneous coronary intervention: systematic review and meta-analysis.Clinical pharmacokinetics and pharmacodynamics of clopidogrel.Adherence to antiplatelet treatment with P2Y12 receptor inhibitors. Is there anything we can do to improve it? A systematic review of randomized trials.Systematic review of the clinical impact of dual antiplatelet therapy discontinuation after acute coronary syndromes.Real world insights on the initiation and treatment duration of oral antiplatelets in acute coronary syndromes: a retrospective cohort study.Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1).Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database.Adherence and persistence with prasugrel following acute coronary syndrome with percutaneous coronary intervention.Impact of left ventricular ejection fraction and medication adherence on major adverse cardiac events during the first year after successful primary percutaneous coronary interventions.Socioeconomic inequality in medication persistence in primary and secondary prevention of coronary heart disease - A population-wide electronic cohort study.Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction.Secondary Prevention Medication After Myocardial Infarction: Persistence in Elderly People over the Course of 1 Year
P2860
Q24289188-3F4A44DD-ECDD-49A3-8921-CDDAD4334CC5Q24633087-266A2E0C-FA44-4DA3-BFFD-6DB67F1DC46FQ27025528-5F538E15-5871-4F9B-87E3-B0B44F954AF9Q28600880-BA578F0F-8238-4239-B4AD-6EF58312818CQ28641211-9BC91437-A23C-4482-AD3D-1F339C1327BEQ28650033-55FB5B0C-C5DF-498D-A167-8E07B2C61C46Q30840122-137EB611-EA68-4CC0-A8E0-700CA683229DQ35086213-0B37CB1B-B986-4968-979D-284F431E3C4AQ35730774-0A0381C1-D107-4C13-9757-1EE0234F1B26Q36108381-4CDEDB50-83FF-441C-A1F2-A6312653BC71Q36143090-5A56CA4D-6932-4B53-BA03-80C73F5BC39EQ36368673-4A00B38B-789D-4445-9BE8-452562202155Q36395016-E75AF22F-E68B-47FD-89E6-40465118026BQ36521022-BCAC2E9D-8E2C-4ED6-B7E8-1DD52E1A2C82Q37066826-61CF8141-31D5-4F09-946B-6D1FEB5FB871Q37067222-2177EDE0-F878-43C3-943E-5B6B63F025AFQ37134004-E293D7CC-C051-4A77-8887-B3889BE2E01CQ37174455-D16666D6-D23D-4A78-BEEA-77CC7FE39AEFQ37606776-1324AE0D-BA2B-4A85-BBF9-13C661AE5888Q38176088-48FC05E1-3EB1-41C0-BE7C-DDE450F40EADQ38195850-3C3B38C8-D185-4B6D-8AD9-1944030FEE93Q38307535-89E7B850-CA22-4E9E-B66D-55959789BAD9Q38817051-8FBF3F7A-3DB4-41D5-B177-E77929245459Q38824526-0324B4AE-98B3-44BA-A6DF-7AFCE3043D3BQ38999087-33FDB1DD-A001-400B-9257-C2523391720EQ39963040-D313433B-B3F2-4394-A355-8344B01F709EQ40272818-9AEB7DA1-DD72-44FC-8552-A3A9BC2B7E36Q45154977-CA749495-C22A-4965-AABA-2EBEE00F7ADBQ50433587-EEBF253F-8DFA-4565-AAEA-196E6E32612DQ52361513-95748D4C-A2E4-458A-A566-76E1A13E95A9Q55004211-226D18E5-358D-4503-9106-C2EFAEA0401DQ57414458-29150784-9BA3-46EE-8318-ACE62EF57989
P2860
Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction--a hospital registry-primary care linked cohort (MINAP-GPRD).
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clopidogrel discontinuation af ...... re linked cohort (MINAP-GPRD).
@ast
Clopidogrel discontinuation af ...... re linked cohort (MINAP-GPRD).
@en
type
label
Clopidogrel discontinuation af ...... re linked cohort (MINAP-GPRD).
@ast
Clopidogrel discontinuation af ...... re linked cohort (MINAP-GPRD).
@en
prefLabel
Clopidogrel discontinuation af ...... re linked cohort (MINAP-GPRD).
@ast
Clopidogrel discontinuation af ...... re linked cohort (MINAP-GPRD).
@en
P2093
P2860
P356
P1476
Clopidogrel discontinuation af ...... are linked cohort (MINAP-GPRD)
@en
P2093
Adam Timmis
Cathy Emmas
Harry Hemingway
Kausik K Ray
Rachael Boggon
P2860
P304
P356
10.1093/EURHEARTJ/EHR340
P577
2011-08-29T00:00:00Z